ASX:DRUG Holdings Information

ASX:DRUG is an equity ETF with a total of 81 individual holdings. The top holdings are Eli Lilly and Company stock at 7.37%, Johnson & Johnson at 6.98%, AbbVie at 6.01%, UnitedHealth Group at 4.61%, and AstraZeneca at 4.26%.

Total Holdings

Top 10 Percentage

47.40%

Asset Class

Equity

ETF Category

Health Care

Assets

155.11M

PE Ratio

20.03

Sector Allocation

Top 25 Holdings

No.	Symbol	Name	% Weight	Shares
1	LLY	Eli Lilly and Company	7.37%	11,907
2	JNJ	Johnson & Johnson	6.98%	44,664
3	ABBV	AbbVie Inc.	6.01%	32,790
4	UNH	UnitedHealth Group Incorporated	4.61%	16,839
5	LON: AZN	AstraZeneca PLC	4.26%	30,291
6	NOVN.SE	NOVARTIS AG	4.00%	36,324
7	ROG.SE	ROCHE HOLDING AG	3.82%	13,573
8	ABT	Abbott Laboratories	3.73%	32,297
9	MRK	Merck & Co., Inc.	3.44%	46,122
10	TMO	Thermo Fisher Scientific Inc.	3.19%	7,376
11	NOVOB.DC	NOVO NORDISK A/S	3.03%	62,931
12	ISRG	Intuitive Surgical, Inc.	2.84%	6,653
13	AMGN	Amgen Inc.	2.59%	9,981
14	DHR	Danaher Corporation	2.44%	13,145
15	SYK	Stryker Corporation	2.40%	7,094
16	GILD	Gilead Sciences, Inc.	2.39%	22,848
17	PFE	Pfizer Inc.	2.35%	105,538
18	BSX	Boston Scientific Corporation	2.30%	25,150
19	MDT	Medtronic plc	1.96%	23,803
20	SAN.FP	SANOFI	1.83%	20,632
21	BMY	Bristol-Myers Squibb Company	1.70%	39,766
22	EL.FP	ESSILORLUXOTTICA SA	1.68%	6,079
23	CI	The Cigna Group	1.38%	5,220
24	VRTX	Vertex Pharmaceuticals Incorporated	1.35%	3,914
25	LON: GSK	GSK plc	1.28%	74,491

As of Aug 18, 2025

Showing 25 of 81

Subscribe to see the full list